This trial suggests that nicotinamide riboside may help hypertensive older adults by enhancing the effects of exercise therapy.
1 Primary · 1 Secondary · Reporting Duration: Baseline; Week 3; Week 6
3 Treatment Groups
1 of 3
NR plus Walking Exercise
1 of 3
Walking Exercise plus Placebo
1 of 3
74 Total Participants · 3 Treatment Groups
Primary Treatment: NR Alone · No Placebo Group · Phase 1
Who is running the clinical trial?
Age 55 - 105 · All Participants · 5 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Are there any vacancies open for participants in this examination?
"Indeed, clinicaltrials.gov reveals that this research venture is currently recruiting subjects. Launched on July 28th 2020 and revised as recently as September 15th 2022, the trial seeks 74 volunteers from a single location." - Anonymous Online Contributor
What is the size of the cohort participating in this clinical trial?
"Affirmative. Clinicaltrials.gov confirms that this medical experiment, initially posted on July 28th 2020 is actively looking for patients to join the study. Currently 74 participants need to be recruited from 1 clinical site." - Anonymous Online Contributor
Have any experiments been conducted to explore the possible benefits of NR Alone?
"Currently, there are 15 active studies being conducted on the effectiveness of NR Alone. One such study is in its final phase. While Winston-Salem, North Carolina houses many of these trials, 19 other sites across the USA have projects related to this treatment underway as well." - Anonymous Online Contributor
Are there significant risks associated with NR Alone?
"Due to its current status as a Phase 1 investigation, the safety of NR Alone was assigned an estimated rating of one. This reflects limited data supporting both efficacy and safety outcomes." - Anonymous Online Contributor
Does this experiment permit persons under the age of seventy to take part?
"For this medical trial, individuals aged between 55 and 105 years are eligible for enrollment." - Anonymous Online Contributor
Are there any eligibility criteria for my participation in this medical research?
"For this hypertension clinical trial, 74 individuals aged between 55 and 105 are being sought. In addition to age requirements, participants must have daytime average systolic BP of at least 130 mmHg but not exceeding 160 mmHg., be inactive with less than 150 minutes per week of moderate physical activity as reported on the CHAMPS questionnaire., consent to randomization into either treatment group and agree to complete all study procedures." - Anonymous Online Contributor